New
HealthMore in Health→
B-Cell Therapies Cut Early MS Relapses, Study Finds
Key Takeaways
- B-cell-depleting therapies were associated with a 62% lower relapse rate than commonly used oral drugs.
- The study followed 509 newly diagnosed MS patients, including 90 who received no early treatment.
- Researchers found no clear difference in disability progression across treatment groups after two years.
DE
DT Editorial Team··via medicalxpress.com